AY-9944

ID: ALA2062162

Max Phase: Preclinical

Molecular Formula: C22H28Cl2N2

Molecular Weight: 391.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Synonyms: AY-9944

Canonical SMILES:  Clc1ccccc1CNC[C@H]1CC[C@H](CNCc2ccccc2Cl)CC1

Standard InChI:  InChI=1S/C22H28Cl2N2/c23-21-7-3-1-5-19(21)15-25-13-17-9-11-18(12-10-17)14-26-16-20-6-2-4-8-22(20)24/h1-8,17-18,25-26H,9-16H2/t17-,18-

Standard InChI Key:  RZRPZWGIOOZIBE-IYARVYRRSA-N

Molfile:  

     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
    1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6003   -1.4978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8990   -0.7455    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2003   -1.4932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4990   -0.7410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8007   -1.4864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0971   -0.7319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0919    0.7681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7903    1.5136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4939    0.7591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3907    1.5203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6919    0.7725    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -12.9906    1.5248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -14.2919    0.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -15.5910    1.5269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -16.8901    0.7769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -16.8900   -0.7231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -15.5910   -1.4731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -14.2920   -0.7231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -2.7000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  -15.5911    2.7269    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  1
 10 11  1  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  6
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
  6 25  1  0
 20 26  1  0
M  END

Associated Targets(Human)

HDAC6 Tclin Histone deacetylase 6 (20808 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 391.39Molecular Weight (Monoisotopic): 390.1630AlogP: 5.68#Rotatable Bonds: 8
Polar Surface Area: 24.06Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.38CX LogP: 5.83CX LogD: 2.48
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.61Np Likeness Score: -0.69

References

1. Pelletier DJ, Gehlhaar D, Tilloy-Ellul A, Johnson TO, Greene N..  (2007)  Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential.,  47  (1): [PMID:17428028] [10.1021/ci6004542]
2. Lowe R, Glen RC, Mitchell JB..  (2010)  Predicting phospholipidosis using machine learning.,  (5): [PMID:20799726] [10.1021/mp100103e]
3. Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF..  (2008)  Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.,  18  (2): [PMID:20020916] [10.1080/15376510701857262]
4. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds,  [10.6019/CHEMBL3301361]
5. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius.  (2021)  HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators,  [10.6019/CHEMBL4808148]